Skip to content
Screener

Shattuck Labs, Inc. STTK Total Operating Expenses

Total Operating Expenses at other companies

Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$57.25M-24.5%
Vor Biopharma logo
Vor BiopharmaVOR
$35.16M+5.6%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
$43.14M-4.7%
MoonLake Immunotherapeutics logo
MoonLake ImmunotherapeuticsMLTX
$70.02M+47.5%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$126.55M+18.4%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$45.64M-14.8%

Segments

By segment

See full
Reportable Segment$16.16M+24.0%

Other financials

Income statement

See full
Revenue-
Operating income-$16.2M-24.0%
Net income-$15.2M-21.6%
EPS (diluted)-$0.12+50.0%

Balance sheet

See full
Cash & equivalents$63.3M+25.4%
Total debt$2.7M-10.0%
Total equity$211.1M+270%
Total assets$220.7M+243%

Cash flow

See full
Operating cash flow-$10.2M+2.4%
CapEx$78.0K
Free cash flow-$10.3M+1.6%

Valuation

See full
Market cap$694.34M+1,861%
Enterprise value$633.72M-5,344%
P/S694.3×+683×

Profitability

See full
Operating margin-5,578.7%-15,316pp
Net margin-5,256.8%-14,625pp
FCF margin-4,124%-23,818pp

Returns & leverage

See full
Return on equity-39.2%-12.5pp
Debt / equity0.0×
Current ratio27.6×+17.3×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Shattuck Labs, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 6:57 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055483
RevenueThree Months Ended June 30, 2026 / $Three Months Ended June 30, 2026 / —Three Months Ended June 30, 2025 / $Three Months Ended June 30, 2025 / —Six Months Ended June 30, 2026 / $Six Months Ended June 30, 2026 / —Six Months Ended June 30, 2025 / $Six Months Ended June 30, 2025 / —
Operating expenses:
Research and development11,7008,68022,64618,599
General and administrative4,4554,3529,0538,822
Expense from operations16,15513,03231,69927,421
Loss from operations(16,155)(13,032)(31,699)(27,421)
Other income (expense)
Interest income1,0298041,8321,416
Other expense(26)(230)(52)(155)

Item 1. Condensed Financial Statements (Unaudited)

FAQ

What is Shattuck Labs, Inc.'s total operating expenses?
Shattuck Labs, Inc. (STTK) reported total operating expenses of $16.16M in Q2 2026.
How has Shattuck Labs, Inc.'s total operating expenses changed year-over-year?
Shattuck Labs, Inc.'s total operating expenses increased by 24.0% year-over-year, from $13.03M to $16.16M.
What is the long-term trend for Shattuck Labs, Inc.'s total operating expenses?
Over 4 years (2021 to 2025), Shattuck Labs, Inc.'s total operating expenses has grown at a -8.6% compound annual growth rate (CAGR), from $75.29M to $52.51M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Ask your AI about Shattuck Labs, Inc.'s total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude